USER MANUAL

CELLA 대표 이미지

CELLA

Instruction for Use

  • MANUAL|CELLA/ELEVEN
Disposable Sterile Do not reuse

DESCRIPTION

This product is a biomaterial for tissue restoration with a derivative of cross-linked sodium hyaluronate originated from bacterial fermentation. It is injected into the skin layer of facial wrinkles and is used for temporal wrinkle improvement.

Item
Value
Item Name
Biomaterial for tissue restoration
Product Name
LUCA CELLA
Purpose of Use
Hyaluronic acid is injected into the subcutaneous layer to restore facial wrinkles or folds of adult through physical restoration.
Storage
Room temperature (2°C~25°C), avoid direct sunlight and freezing.
Package unit
1 pre-filled syringe / 25G-2 needle per box

COMPOSITION

Component
Content
Cross-linked sodium hyaluronate
24 mg/mL
Phosphate buffered saline
q.s.

WARNINGS AND INCOMPATIBILITIES

  • Be sure to understand the user's manual before use.
  • Inspect the sealed inner packaging before use for damage or defects; do not use if any are found.
  • Check the expiration date on the product before use.
  • Because it is a disposable sterile product, it must not be reused and do not re-sterilize.
  • Do not bend or break the needle for use.
  • Contraindicated for patients with: hypersensitivity to hyaluronic acid, history of severe allergy or anaphylaxis, tendency for keloid/hypertrophic scar, bleeding-related disorder, bacterial allergy.
  • If injected into blood vessels, serious side effects (e.g., blindness) may occur. Avoid use in thin-skin areas with high vascular injection risk; use special caution.
  • Do not use near blood vessels (periocular site) to avoid vision impairment and tissue necrosis.
  • Should not be used in combination with laser treatment, chemical peeling, dermabrasion, or other surgical methods.
  • Excessive use should be avoided; do not inject to epithelium.

CAUTIONS

  • Procedure should be performed by a doctor sufficiently trained in treatment using this product.
  • Before the procedure, inform the patient about indications, contraindications, and potential side effects.
  • Confirm no product damage; check expiration date.
  • Observe patient’s skin condition after the procedure.
  • Resolve issues such as pimples or open pores before the procedure to prevent leakage.
  • Disinfect injection site and surrounding tissue before use.
  • If injected to the epithelium, blanching occurs; inject into the dermis.
  • When combined with other anesthetics, pay attention to systemic toxicity; high doses may cause CNS or cardiovascular toxicity.
  • Medication may cause local redness or hypersensitivity.
  • Before the procedure, prohibit aspirin, NSAIDs, or vitamins.
  • Recommend no makeup for 24 hours post-procedure; avoid sunlight, extreme cold, and sauna for 2 weeks.

INTERACTIONS

Hyaluronic acid may cause precipitation with quaternary ammonium compounds such as benzalkonium chloride (sanitizer/disinfectant). Do not use in combination with, or allow contact between, these substances (or instruments that contacted them) and this product.

SIDE EFFECTS

The practitioner should explain that the following symptoms may appear immediately after injection or later and to seek care if symptoms persist.

  • Bruise, inflammation, edema (swelling), pain, skin discoloration.
  • Allergic reactions, inflammatory reactions (abscess), infections, tissue necrosis at injection site.
  • Filler leakage through an opened procedure site; movement to another location; permanent bump formation.
  • Visual impairments, including blindness, particularly with intravascular injection or periocular use.

In case inflammation or other side effects persist for more than one week, the patient should consult a doctor at once and receive treatment.

Adverse events reported with systemic lidocaine

  • Shock, malignant hyperthermia (rare), CNS symptoms (drowsiness, dizziness, anxiety, apnea, convulsions, coma), cardiovascular symptoms (hypotension, bradycardia, cardiac arrest), hypersensitivity (rash, hives, edema, anaphylactic shock).

METHOD OF USE

  • Use by licensed medical professionals only. Thoroughly read the user manual about indications, contraindications, and potential side effects.
  • Check product integrity and expiration date before use.
  • Inject into the dermis; disinfect thoroughly prior to injection.
  • Connect the enclosed needle and remove air; replace if contaminated.
  • Inject an appropriate amount as required; massage lightly after injection to shape the area.

STORAGE AND DISPOSAL AFTER USE

  • Store sealed at 2°C–25°C; avoid direct sunlight and freezing.
  • Do not reuse; discard used syringes, needles, and remaining gel after treatment according to local regulations.

ASSEMBLY OF NEEDLE TO SYRINGE

For safe use, properly assemble the needle to the syringe.

  1. Hold the luer lock adapter of the syringe between the index finger and thumb.
  2. With the other hand, firmly push and screw the needle on clockwise. Improper assembly can cause needle disengagement or leakage.
  3. Remove the protective cap by holding the luer-lock and pulling in opposite directions.

DIAGRAM

CELLA Diagram

SYMBOLS USED ON LABELING

CELLA Symbols
Disposable Sterile Do not reuse

DESCRIPTION

This product is a biomaterial for tissue restoration with a derivative of cross-linked sodium hyaluronate originated from bacterial fermentation. It is injected into the skin layer of facial wrinkles and is used for temporal wrinkle improvement. Lidocaine has the effect of reducing pain during treatment.

Item
Value
Item Name
Biomaterial for tissue restoration
Product Name
LUCA CELLA ELEVEN
Purpose of Use
Hyaluronic acid with lidocaine is injected into the subcutaneous layer to restore facial wrinkles or folds of adult through physical restoration.
Storage
Room temperature (2°C~25°C), avoid direct sunlight and freezing.
Package unit
1 pre-filled syringe / 25G-2 needle per box

COMPOSITION

Component
Content
Cross-linked sodium hyaluronate
24 mg/mL
Lidocaine Hydrochloride
3 mg/mL
Phosphate buffered saline
q.s.

WARNINGS AND INCOMPATIBILITIES

  • Be sure to understand the user's manual before use.
  • Inspect the sealed inner packaging before use for damage or defects; do not use if any are found.
  • Check the expiration date on the product before use.
  • Because it is a disposable sterile product, it must not be reused and do not re-sterilize.
  • Do not bend or break the needle for use.
  • Contraindicated for patients with: hypersensitivity to lidocaine or amide-type local anesthetics; severe allergy/anaphylaxis history; tendency for keloid/hypertrophic scar; porphyria; autoimmune skin disease; bleeding-related disorders; bacterial or blood allergy; pregnant or lactating women.
  • If injected into blood vessels, serious side effects (e.g., blindness) may occur. Avoid use in thin-skin areas with high vascular injection risk; use special caution.
  • Do not use near blood vessels (periocular site) to avoid vision impairment and tissue necrosis.
  • Should not be used in combination with laser treatment, chemical peeling, dermabrasion, or other surgical methods.
  • Excessive use should be avoided; do not inject to epithelium.

CAUTIONS

  • Procedure should be performed by a doctor sufficiently trained in treatment using this product.
  • Before the procedure, inform the patient about indications, contraindications, and potential side effects.
  • Confirm no product damage; check expiration date.
  • Observe patient’s skin condition after the procedure.
  • Resolve issues such as pimples or open pores before the procedure to prevent leakage.
  • Disinfect injection site and surrounding tissue before use.
  • If injected to the epithelium, blanching occurs; inject into the dermis.
  • Use caution in patients sensitive to lidocaine or amide-type local anesthetics.
  • When combined with other anesthetics (including dental block), determine lidocaine amount/time appropriately. High doses (≥400 mg) may cause CNS or cardiovascular toxicity.
  • Medication may cause local redness or hypersensitivity.
  • Before the procedure, prohibit aspirin, NSAIDs, or vitamins.
  • Use lidocaine cautiously in patients with epilepsy, ECG abnormalities, or respiratory disorders.
  • Recommend no makeup for 24 hours post-procedure; avoid sunlight, extreme cold, and sauna for 2 weeks.

INTERACTIONS

Hyaluronic acid may cause precipitation with quaternary ammonium compounds such as benzalkonium chloride (sanitizer/disinfectant). Do not use in combination with, or allow contact between, these substances (or instruments that contacted them) and this product.

SIDE EFFECTS

The practitioner should explain that the following symptoms may appear immediately after injection or later and to seek care if symptoms persist.

  • Bruise, inflammation, edema (swelling), pain, skin discoloration.
  • Allergic reactions and facial abnormalities (rash, hives), inflammatory reactions (abscess), infections, tissue necrosis at injection site.
  • Filler leakage through an opened procedure site; movement to another location; permanent bump formation.
  • Visual impairments, including blindness, particularly with intravascular injection or periocular use.

In case inflammation or other side effects persist for more than one week, the patient should consult a doctor at once and receive treatment.

Adverse events reported with systemic lidocaine

  • Shock: monitor carefully; treat hypotension, pallor, abnormal pulse, respiratory depression appropriately.
  • Malignant hyperthermia (rare): irregular tachycardia/arrhythmia, blood pressure fluctuations, hyperthermia, muscle rigidity, dark urine, hyperkalemia, myoglobinuria, acidosis, hypernatremia. Discontinue and treat (e.g., IV dantrolene); monitor renal function.
  • Central nervous system: drowsiness, dizziness, anxiety, excitement, apnea, convulsions, coma; treat appropriately (e.g., barbiturate/diazepam).
  • Cardiovascular system: hypotension, bradycardia, cardiac arrest; administer appropriate treatment.
  • Hypersensitivity: rash, hives, edema, anaphylactic shock may occur.

METHOD OF USE

  • Use by licensed medical professionals only. Thoroughly read the user manual about indications, contraindications, and potential side effects.
  • Check product integrity and expiration date before use.
  • Inject into the dermis; disinfect thoroughly prior to injection.
  • Connect the enclosed needle and remove air; replace if contaminated.
  • Inject an appropriate amount as required; massage lightly after injection to shape the area.

STORAGE AND DISPOSAL AFTER USE

  • Store sealed at 2°C–25°C; avoid direct sunlight and freezing.
  • Do not reuse; discard used syringes, needles, and remaining gel after treatment according to local regulations.

ASSEMBLY OF NEEDLE TO SYRINGE

For safe use, properly assemble the needle to the syringe.

  1. Hold the luer lock adapter of the syringe between the index finger and thumb.
  2. With the other hand, firmly push and screw the needle on clockwise. Improper assembly can cause needle disengagement or leakage.
  3. Remove the protective cap by holding the luer-lock and pulling in opposite directions.

SYMBOLS USED ON LABELING

CELLA ELEVEN Symbols